A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.

2.50
Hdl Handle:
http://hdl.handle.net/11287/604005
Title:
A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.
Authors:
Townsend, W.; Johnson, R. J.; Pottinger, B. T.; Counsell, N.; Smith, P.; Chadwick, H.; Evans, Katy; Wickham, Caroline; Rudin, Claudius E.
Citation:
A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320. 2016:1-3 Leuk. Lymphoma
Publisher:
Taylor & Francis
Journal:
Leukemia & lymphoma
Issue Date:
22-Mar-2016
URI:
http://hdl.handle.net/11287/604005
DOI:
10.3109/10428194.2015.1133814
PubMed ID:
27001186
Additional Links:
http://www.tandfonline.com/doi/full/10.3109/10428194.2015.1133814
Type:
Letter
Language:
en
ISSN:
1029-2403
Appears in Collections:
Clinical Haematology; 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTownsend, W.en
dc.contributor.authorJohnson, R. J.en
dc.contributor.authorPottinger, B. T.en
dc.contributor.authorCounsell, N.en
dc.contributor.authorSmith, P.en
dc.contributor.authorChadwick, H.en
dc.contributor.authorEvans, Katyen
dc.contributor.authorWickham, Carolineen
dc.contributor.authorRudin, Claudius E.en
dc.date.accessioned2016-03-30T12:31:13Zen
dc.date.available2016-03-30T12:31:13Zen
dc.date.issued2016-03-22en
dc.identifier.citationA phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320. 2016:1-3 Leuk. Lymphomaen
dc.identifier.issn1029-2403en
dc.identifier.pmid27001186en
dc.identifier.doi10.3109/10428194.2015.1133814en
dc.identifier.urihttp://hdl.handle.net/11287/604005en
dc.languageENGen
dc.language.isoenen
dc.publisherTaylor & Francisen
dc.relation.urlhttp://www.tandfonline.com/doi/full/10.3109/10428194.2015.1133814en
dc.rightsArchived with thanks to Leukemia & lymphomaen
dc.subjectWessex Classification Subject Headings::Haematologyen
dc.titleA phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.en
dc.typeLetteren
dc.identifier.journalLeukemia & lymphomaen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.